SOP Guide for Pharma

Analytical Method Development: System Suitability Limits Design for HPLC – V 2.0

Auditor

Analytical Method Development: System Suitability Limits Design for HPLC – V 2.0

SOP for Designing System Suitability Limits in HPLC Method Development


Department Analytical Method Development
SOP No. SOP/AMD/082/2025
Supersedes SOP/AMD/082/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP provides a structured approach for designing and evaluating system suitability parameters during HPLC method development. Establishing robust system suitability ensures chromatographic system integrity and reliable analytical results.

2. Scope

This procedure applies to all HPLC-based analytical methods developed and validated in the Analytical Method Development (AMD) laboratory for pharmaceutical raw materials, intermediates, and finished drug products.

3. Responsibilities

  • Analytical Chemist: Designs, executes, and evaluates system suitability tests and documents results.
  • Reviewer: Verifies compliance of system suitability parameters with acceptance criteria.
  • QA Officer: Ensures documentation aligns with regulatory standards.
  • Head – AMD: Approves system suitability limits before method validation or transfer.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring system suitability limits are scientifically justified and documented for each HPLC method developed.

See also  Analytical Method Development: SOP for Nanoformulations Analysis Method - V 2.0

5. Procedure

5.1 Identification of System Suitability Parameters

  1. Determine applicable parameters based on method type:
    • Assay/related substances: Resolution, %RSD, tailing factor
    • Impurity profiling: LOD/LOQ, S/N ratio
    • Dissolution or uniformity: Retention time consistency
  2. Document in Annexure-1: Suitability Parameter Planning Sheet.

5.2 Experimental Determination of Limits

  1. Inject standard solution (n=5–6 replicates) at target concentration.
  2. Measure the following:
    • Retention time (RT)
    • Peak area and %RSD
    • Resolution (Rs) between critical peaks
    • Tailing factor
    • Theoretical plates (efficiency)
  3. Calculate mean, %RSD, and define acceptance limits based on observed variability.
  4. Example: If mean tailing factor = 1.10 with %RSD = 0.4%, acceptable limit = ≤1.5.
  5. Record in Annexure-2: Experimental Results Log.

5.3 Criteria for Limit Setting

  1. Follow regulatory guidelines and best practices:
    • %RSD for replicate injections: ≤ 2.0% for assay; ≤ 5.0% for impurities
    • Tailing Factor: ≤ 2.0
    • Resolution: ≥ 2.0 between critical pairs
    • Plate Count: ≥ 2000 for assay; ≥ 1000 for impurities
  2. If observed results are tighter, set stricter in-house limits (e.g., %RSD ≤ 1.5%).
  3. Document final selected limits in Annexure-3: Final Suitability Limits Sheet.
See also  Analytical Method Development: SOP for Conducting Forced Degradation Study - V 2.0

5.4 System Suitability Protocol Execution

  1. Prepare fresh standard solution at working concentration.
  2. Inject standard (minimum 5 replicates).
  3. Evaluate against defined limits.
  4. Document compliance in Annexure-4: Routine System Suitability Report.

5.5 Investigation and Troubleshooting

  1. If limits are not met, perform checks:
    • Re-prepare mobile phase and standards
    • Replace column or injector components
    • Clean system lines and autosampler
  2. Document corrective actions in Annexure-5: System Suitability Deviation Log.

5.6 Integration with Method Validation

  1. System suitability limits must be included in method validation protocols and reports.
  2. Limits should be verified during each validation parameter (precision, linearity, robustness).
  3. Include as a section in final Method Development Report and SOP.

6. Abbreviations

  • HPLC: High-Performance Liquid Chromatography
  • RT: Retention Time
  • Rs: Resolution
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure

7. Documents

  1. Suitability Parameter Planning Sheet – Annexure-1
  2. Experimental Results Log – Annexure-2
  3. Final Suitability Limits Sheet – Annexure-3
  4. Routine System Suitability Report – Annexure-4
  5. System Suitability Deviation Log – Annexure-5
See also  Analytical Method Development: SOP for Sterility Testing Method Transfer to QC - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <621> – Chromatography
  • FDA Guidance for Industry – Analytical Procedures and Methods Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Suitability Parameter Planning Sheet

Parameter Justification Applicable To
Resolution Impurity separation Impurity method
%RSD Precision check Assay/Content Uniformity

Annexure-2: Experimental Results Log

Injection No. RT Area Tailing Plate Count
1 4.25 106574 1.11 3200

Annexure-3: Final Suitability Limits Sheet

Parameter Limit Rationale
%RSD ≤ 1.5% Observed RSD from replicates
Resolution ≥ 2.0 Regulatory compliance

Annexure-4: Routine System Suitability Report

Parameter Value Status
%RSD (n=5) 1.22% Complies

Annexure-5: System Suitability Deviation Log

Date Issue Action Taken Verified By
17/05/2025 High tailing factor Column replaced Sunita Reddy

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included deviation log and rationale annexure Annual SOP Review
Exit mobile version